Publications
We introduce books, articles and other materials authored or co-authored by, and interviews with, ABE & PARTNERS attorneys.
-
"FRAND declared SEPs and a warning letter"
- Newsletter
- IP Disputes
- IP Transactions
- IT and Telecommunications
- International Disputes
- Cross-Border Transactions
- Antitrust/Competition
-
"FRAND declared SEPs and a warning letter"
Source : Managing Intellectual Property (SPRING 2022)- Article
- IP Disputes
- IP Transactions
- IT and Telecommunications
- International Disputes
- Cross-Border Transactions
- Antitrust/Competition
-
"Will authorised biologics deter biosimilars? Utilising JFTC’s expertise in drug pricing"
Source : Life Sciences Intellectual Property Review- Article
- Life Science and Health Care
- Antitrust/Competition
-
"SEPs and the automotive industry in Japan"
- Newsletter
- IP Disputes
- IP Transactions
- IT and Telecommunications
- International Disputes
- Cross-Border Transactions
- Antitrust/Competition
-
"SEPs and the automotive industry in Japan"
Source : WIPR Patents Live- Article
- IP Disputes
- IP Transactions
- IT and Telecommunications
- International Disputes
- Cross-Border Transactions
- Antitrust/Competition
-
"Competition Law and Policy in the Japanese Pharmaceutical Sector"
Source : Springer l OA CC BY-NC-ND 4.0 International License- Book
- Life Science and Health Care
- Antitrust/Competition
-
"Japan Supreme Court acquits defendant in Coinhive case"
- Newsletter
- IT and Telecommunications
-
"Japan Supreme Court acquits defendant in Coinhive case"
Source : Managing Intellectual Property (SPRING 2022)- Article
- IT and Telecommunications
-
"JPO must stay neutral in its SEP policy review, urge sources"
Source : Managing Intellectual Property Magazine- Interview
- IP Disputes
- IP Transactions
- IT and Telecommunications
- International Disputes
- Cross-Border Transactions
- Antitrust/Competition
-
"Asia patent trends in 2022: SEP rates, court changes and more"
Source : Managing Intellectual Property Magazine- Interview
- IP Disputes
- IP Transactions
- Life Science and Health Care
- IT and Telecommunications
- International Disputes
- Cross-Border Transactions
- Antitrust/Competition
-
"Council discusses availability of iPS patents"
Source : Yomiuri Newspaper- Interview
- IP Disputes
- Life Science and Health Care
-
"Directors’ liability for patent infringement pursuant to the Companies Act"
Source : Managing Intellectual Property Magazine (WINTER 2021)- Article
- IP Disputes
- General Corporate
- Restructuring and Insolvency
-
"Directors’ liability for patent infringement pursuant to the Companies Act"
- Newsletter
- IP Disputes
- General Corporate
- Restructuring and Insolvency
-
"A new drug pricing system reform proposal in Japan"
- Newsletter
- Life Science and Health Care
-
"A new drug pricing system reform proposal in Japan"
Source : Life Sciences Intellectual Property Review (2021’s most-read contributed articles)- Article
- Life Science and Health Care
-
"Will Authorised Biologics deter Biosimilars? - Utilising JFTC's expertise in drug pricing -"
Source : Fair Trade Magazine (August 2021)- Article
- Life Science and Health Care
- Antitrust/Competition
-
"Assessing the licensing environment of SEPs in Japan"
- Newsletter
- IP Disputes
- IP Transactions
- IT and Telecommunications
- International Disputes
- Cross-Border Transactions
- Antitrust/Competition
-
"Assessing the licensing environment of SEPs in Japan"
Source : Managing Intellectual Property Magazine (SUMMER 2021)- Article
- IP Disputes
- IP Transactions
- IT and Telecommunications
- International Disputes
- Cross-Border Transactions
- Antitrust/Competition
-
"Clinical trials for original drugs fall under experimental use exception"
- Newsletter
- IP Disputes
- Life Science and Health Care
-
"Clinical trials for original drugs fall under experimental use exception"
Source : LSPN Connect- Article
- IP Disputes
- Life Science and Health Care
-
"A closer look at Japan’s desirable patent system in the era of COVID-19"
- Newsletter
- IP Disputes
- IP Transactions
- Life Science and Health Care
- IT and Telecommunications
- International Disputes
- Cross-Border Transactions
-
"The strategic acquisition and utilisation of SEPs: reviewing Japan’s IP Promotion Plan 2021"
- Newsletter
- IP Disputes
- IP Transactions
- IT and Telecommunications
- International Disputes
- Cross-Border Transactions
- Antitrust/Competition
-
"The strategic acquisition and utilisation of SEPs: reviewing Japan’s IP Promotion Plan 2021"
Source : Managing Intellectual Property Magazine (SUMMER 2021)- Article
- IP Disputes
- IP Transactions
- IT and Telecommunications
- International Disputes
- Cross-Border Transactions
- Antitrust/Competition
-
"U.S. Patent Litigation Update : The Resurgence of Patent Trolls"
- Newsletter
- IP Disputes
- Life Science and Health Care
- IT and Telecommunications
- International Disputes
-
"A closer look at Japan’s desirable patent system in the era of COVID-19"
Source : Managing Intellectual Property Magazine (SUMMER 2021)- Article
- IP Transactions
- Life Science and Health Care
- IT and Telecommunications
- Cross-Border Transactions
-
"Reviewing the JPO’s Hantei (Advisory Opinion) for Essentiality Check"
- Newsletter
- IP Disputes
- IP Transactions
- IT and Telecommunications
- International Disputes
- Cross-Border Transactions
- Antitrust/Competition
-
"Reviewing the JPO’s Hantei (Advisory Opinion) for Essentiality Check"
Source : Managing Intellectual Property Magazine (SUMMER 2021)- Article
- IP Disputes
- IP Transactions
- IT and Telecommunications
- International Disputes
- Cross-Border Transactions
- Antitrust/Competition
-
"Damages awarded based on LED-equipped TV for LED patent infringement"
Source : Managing Intellectual Property Magazine (SUMMER 2021)- Article
- IP Disputes
-
"Damages awarded based on LED-equipped TV for LED patent infringement"
- Newsletter
- IP Disputes
-
"Courts rule on likelihood of confusion in medical device case"
Source : Managing Intellectual Property Magazine (WINTER 2020)- Article
- IP Disputes
- Life Science and Health Care
-
"Courts rule on likelihood of confusion in medical device case"
- Newsletter
- IP Disputes
- Life Science and Health Care
-
"Matsukiyo-Cocokara merger to create leading drugstore will benefit from regulatory changes"
Source : PaRR- Interview
- Life Science and Health Care
- M&A
- Antitrust/Competition
-
"Japanese government launches SEP advisory panel with renewed focus on competition"
Source : PaRR- Interview
- IP Disputes
- IP Transactions
- IT and Telecommunications
- International Disputes
- Cross-Border Transactions
- Antitrust/Competition
-
"Utilizing mediation in patent dispute"
Source : Nikkei Newspaper- Interview
- IP Disputes
- Life Science and Health Care
- IT and Telecommunications
- Antitrust/Competition
-
"Antimonopoly Act defence proves successful against patent enforcement"
- Newsletter
- IP Disputes
- Antitrust/Competition
-
"Antimonopoly Act defence proves successful against patent enforcement"
Source : Managing Intellectual Property Magazine (SPRING 2021)- Article
- IP Disputes
- Antitrust/Competition
-
"Rituximab biosimilar patent infringement lawsuit"
- Newsletter
- IP Disputes
- Life Science and Health Care
-
"Rituximab biosimilar patent infringement lawsuit"
Source : LSPN Connect- Article
- IP Disputes
- Life Science and Health Care
-
"Japan’s SEP essentiality assessment system gains interest in Europe"
Source : PaRR- Interview
- IP Disputes
- IP Transactions
- IT and Telecommunications
- International Disputes
- Cross-Border Transactions
- Antitrust/Competition
-
"The Broad Institute’s CRISPR-Cas9 patents"
Source : LSPN Connect- Article
- IP Disputes
- Life Science and Health Care
-
"The Broad Institute’s CRISPR-Cas9 patents"
- Newsletter
- IP Disputes
- Life Science and Health Care
-
"How was Japanese patent litigation reformed?"
Source : Managing Intellectual Property Magazine (WINTER 2020)- Article
- IP Disputes
- Life Science and Health Care
- IT and Telecommunications
-
"How was Japanese patent litigation reformed"
- Newsletter
- IP Disputes
- Life Science and Health Care
- IT and Telecommunications
-
"Why reverse payment is unlikely to arise in Japan?"
Source : Fair Trade magazine (November 2020)- Article
- IP Disputes
- Life Science and Health Care
- Antitrust/Competition
-
"Inventor of anti-PD-L1 antibody patent"
Source : LSPN Connect- Article
- IP Disputes
- Life Science and Health Care
-
"Inventor of anti-PD-L1 antibody patent"
- Newsletter
- IP Disputes
- Life Science and Health Care
-
"Fair value calculation of SEPs for multi-component products"
Source : Managing Intellectual Property Magazine (WINTER 2020)- Article
- IP Disputes
- IP Transactions
- IT and Telecommunications
- International Disputes
- Cross-Border Transactions
- Antitrust/Competition
-
"Fair value calculation of SEPs for multi-component products"
- Newsletter
- IP Disputes
- IP Transactions
- IT and Telecommunications
- International Disputes
- Cross-Border Transactions
- Antitrust/Competition
-
"Japan implements new IP mediation proceedings"
Source : Managing Intellectual Property Magazine(Online)- Article
- IP Disputes
-
"New IP Mediation Proceedings"
- Newsletter
- IP Disputes
- Life Science and Health Care
- IT and Telecommunications
